HJC0152 suppresses human non–small‐cell lung cancer by inhibiting STAT3 and modulating metabolism

OBJECTIVES: Signal transducer and activator of transcription 3 (STAT3) is constitutively activated and overexpressed in many cancers, including non–small‐cell lung cancer (NSCLC). We recently developed HJC0152 as an orally active STAT3 inhibitor. This study focused on investigating HJC0152's ef...

Full description

Saved in:
Bibliographic Details
Published in:Cell Prolif
Main Authors: Lu, Lu, Li, Hang, Wu, Xin, Rao, Jun, Zhou, Jia, Fan, Saijun, Shen, Qiang
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7106968/
https://ncbi.nlm.nih.gov/pubmed/32022328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12777
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items